Biernacki Marek
Department of Mathematics and Cybernetics, Wrocław University of Economics and Business, Wrocław, Poland.
Front Public Health. 2025 Jul 8;13:1592384. doi: 10.3389/fpubh.2025.1592384. eCollection 2025.
The aim of this study was to determine the extent to which the national healthcare systems of European Union countries used their medical potential in the fight against COVID-19. The analyzed period covered the years before the pandemic 2009-2018 and the COVID-19 pandemic. The analysis was conducted for all European Union's countries. It concerned the evaluation not only of the effectiveness of treatment, but also of the efficiency, i.e., the use of resources in healthcare systems.
Descriptive and analytical study on EUROSTAT data, Health Consumer Powerhouse, OECD Health Statistics, European Health Interview Survey (EHIS) and World Health Organization (WHO).
An index was proposed to measure the quality of healthcare systems' activities, which simultaneously assesses the effectiveness and efficiency of treatment. The treatment results depend not only on management, but also on financial resources. EHCI, HLY, % of unmet medical needs were used to assess the effectiveness of treatment. Efficiency was calculated using with the DEA method based on total healthcare expenditure per capita at purchasing power parity. The final assessment is based on the difference in the index value from the pandemic period and before the COVID-19 pandemic.
The healthcare systems of small EU countries coped most effectively and efficiently during the COVID-19 pandemic: Denmark (0.6), Estonia (0.5), Austria (0.5), Slovenia (0.3), and the Czech Republic (0.3). However, large and non-rich EU countries fared much worse: Spain (-0.8), Hungary (-0.7) and Poland (-0.4). This group also unexpectedly included the Netherlands (-0.3)-a small, wealthy country that coped poorly with the challenges posed by the COVID-19 pandemic.
Based on the analysis carried out in this paper, it can be concluded that the optimal (efficient and effective) use of medical resources did not depend only on the state of ownership and technological advancement of healthcare systems (!). The involvement of medical staff, society, and decisions of state authorities were equally significant.
本研究的目的是确定欧盟国家的国家医疗保健系统在抗击新冠疫情中利用其医疗潜力的程度。分析期涵盖大流行前的2009 - 2018年以及新冠疫情期间。分析针对所有欧盟国家进行。它不仅涉及治疗效果的评估,还涉及效率评估,即医疗保健系统中资源的利用情况。
基于欧盟统计局数据、健康消费者力量机构、经合组织卫生统计、欧洲健康访谈调查(EHIS)和世界卫生组织(WHO)的描述性和分析性研究。
提出了一个衡量医疗保健系统活动质量的指标,该指标同时评估治疗的有效性和效率。治疗结果不仅取决于管理,还取决于财政资源。使用EHCI、健康预期寿命(HLY)、未满足医疗需求的百分比来评估治疗效果。效率是基于购买力平价下的人均医疗总支出,采用数据包络分析(DEA)方法计算得出。最终评估基于疫情期间与新冠疫情之前指数值的差异。
在新冠疫情期间,欧盟小国的医疗保健系统应对最为有效和高效:丹麦(0.6)、爱沙尼亚(0.5)、奥地利(0.5)、斯洛文尼亚(0.3)和捷克共和国(0.3)。然而,欧盟的大国和非富裕国家表现要差得多:西班牙(-0.8)、匈牙利(-0.7)和波兰(-0.4)。这个群体中还意外地包括荷兰(-0.3)——一个富裕的小国,在应对新冠疫情带来的挑战方面表现不佳。
基于本文所进行的分析,可以得出结论,医疗资源的最优(高效且有效)利用不仅仅取决于医疗保健系统的所有制状况和技术进步(!)。医务人员、社会的参与以及国家当局的决策同样重要。